Skip to content
10-K

Annual Report

VYCOR MEDICAL, INC. VYCO

0001493152-26-014036

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 31, 2026 33.37M sh
Shares Diluted FY 2025 · Dec 31, 2025 33.37M sh
Shares Diluted FY 2025 · Dec 31, 2024 32.88M sh
Capex FY 2025 · Dec 31, 2025 $5.22K
Capex restated FY 2025 · Dec 31, 2024 $5.37K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$13.47K
Operating Cash Flow FY 2025 · Dec 31, 2024 $60.11K
Cash And Equivalents FY 2025 · Dec 31, 2025 $86.98K
Cash And Equivalents FY 2025 · Dec 31, 2024 $105.65K
Stockholders Equity FY 2025 · Dec 31, 2025 −$4.09M
Stockholders Equity FY 2025 · Dec 31, 2024 −$3.69M
Stockholders Equity FY 2025 · Dec 31, 2023 −$3.33M
Current Liabilities FY 2025 · Dec 31, 2025 $4.78M
Current Liabilities FY 2025 · Dec 31, 2024 $4.5M
Total Liabilities FY 2025 · Dec 31, 2025 $4.92M
Total Liabilities FY 2025 · Dec 31, 2024 $4.69M
Current Assets FY 2025 · Dec 31, 2025 $563.42K
Current Assets restated FY 2025 · Dec 31, 2024 $619.61K
Total Assets FY 2025 · Dec 31, 2025 $830.42K
Total Assets FY 2025 · Dec 31, 2024 $998.12K
Eps Diluted FY 2025 · Dec 31, 2025 −$0.01
Eps Diluted FY 2025 · Dec 31, 2024 −$0.01
Eps Basic FY 2025 · Dec 31, 2025 −$0.01
Eps Basic FY 2025 · Dec 31, 2024 −$0.01
Sga Expense FY 2025 · Dec 31, 2025 $1.46M
Sga Expense FY 2025 · Dec 31, 2024 $1.36M
Rd Expense FY 2025 · Dec 31, 2025 $9.96K
Rd Expense FY 2025 · Dec 31, 2024 $15.33K
Net Income FY 2025 · Dec 31, 2025 −$72.43K
Net Income FY 2025 · Dec 31, 2024 −$107.2K
Operating Income FY 2025 · Dec 31, 2025 $33.9K
Operating Income FY 2025 · Dec 31, 2024 −$9.15K
Gross Profit FY 2025 · Dec 31, 2025 $1.56M
Gross Profit FY 2025 · Dec 31, 2024 $1.42M
Cost Of Revenue FY 2025 · Dec 31, 2025 $302.29K
Cost Of Revenue FY 2025 · Dec 31, 2024 $166.81K
Revenue FY 2025 · Dec 31, 2025 $1.86M
Revenue FY 2025 · Dec 31, 2024 $1.59M